NWMG
NVCR icon

National Wealth Management Group’s NovoCure NVCR Stock Holding History

National Wealth Management Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,068
Closed -$309K – 154
2022
Q3 		$309K Buy
+4,068
New +$317K 0.4% 82

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Wealth Management Group's NVCR Position: Q4 2022 in Review

National Wealth Management Group sold out of NovoCure (NVCR) in Q4 2022, closing a stake of 4,068 shares — an estimated $309K sold.

National Wealth Management Group first reported a position in NVCR in Q3 2022 and held it in 1 quarter. The position peaked at $309K in Q3 2022. 304 funds tracked by Wall St. Rank hold NVCR as of Q4 2022.

  • National Wealth Management Group reported no remaining NovoCure position as of Q4 2022 after selling out during the quarter.
  • National Wealth Management Group sold 4,068 NovoCure shares in Q4 2022, an estimated $309K.
  • National Wealth Management Group first reported a position in NovoCure in Q3 2022 and held it in 1 quarter.
  • National Wealth Management Group's NovoCure position peaked at $309K in Q3 2022.
  • 304 funds tracked by Wall St. Rank held NovoCure as of Q4 2022.

Based on National Wealth Management Group's 13F filing for Q4 2022, filed 17 Nov 2023.